Telaprevir combination therapy in treatment-naive and experienced patients co-infected with HCV and HIV

被引：0

作者：

Montes, Marisa ^{[1
]}

Nelson, Mark ^{[2
]}

Girard, Marie ^{[3
]}

Sasadeusz, Joe ^{[4
]}

Horban, Andrzej ^{[5
]}

Grinsztejn, Beatriz ^{[6
]}

Zakharova, Natalia ^{[7
]}

Falconer, Karolin ^{[8
]}

Dierynck, Inge ^{[9
]}

Luo, Donghan ^{[10
]}

Ma, Yi-Wen ^{[10
]}

Witek, James ^{[10
]}

机构：

[1] Hosp La Paz, Madrid, Spain

[2] Chelsea & Westminster Hosp, London, England

[3] Hop St Antoine, Paris, France

[4] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia

[5] Hosp Infect Dis, Warsaw, Poland

[6] Inst Pesquisa Clin Evandro Chagas, STD AIDS Clin Res Lab, Rio De Janeiro, Brazil

[7] St Petersburg AIDS Ctr, St Petersburg, Russia

[8] Karolinska Univ Hosp, Stockholm, Sweden

[9] Janssen Infect Dis BVBA, Beerse, Belgium

[10] Janssen Res & Dev LLC, Titusville, NJ USA

来源：

HEPATOLOGY | 2013年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：225A / 226A

页数：2

共 50 条

[1] Telaprevir combination therapy in treatment-naive and -experienced patients co-infected with HCV/HIV (INSIGHT STUDY): sustained virologic response at 12 weeks final analysis
Montes, Marisa L.
Nelson, Mark
Girard, Pierre-Marie
Sasadeusz, Joe
Horban, Andrzej
Grinsztejn, Beatriz
Zakharova, Natalia
Rivero, Antonio
Lathouwers, Erkki
Janssen, Katrien
Ouwerkerk-Mahadevan, Sivi
Witek, James
HEPATOLOGY, 2014, 60 : 678A - 678A
[2] Combination therapy recommended for patients co-infected with HIV and HCV
不详
BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (09) : 489 - 489
[3] Monitoring renal function during combination therapy with telaprevir in HIV/HCV co-infected patients with advanced/fibrosis cirrhosis
Puzzolante, Cinzia
Vecchia, Marco
Zona, Stefano
Borghi, Vanni
Guaraldi, Giovanni
Mussini, Cristina
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 91 - 92
[4] Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naive HIV/HCV Co-Infected Patients in China
Zhou, Kali
Liang, Zhiwei
Wang, Charles
Hu, Fengyu
Ning, Chuanyi
Lan, Yun
Tang, Xiaoping
Tucker, Joseph D.
Cai, Weiping
PLOS ONE, 2016, 11 (06):
[5] Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients
Sherman, Kenneth E.
Guedj, Jeremie
Shata, Mohamed Tarek
Blackard, Jason T.
Rouster, Susan D.
Castro, Mario
Feinberg, Judith
Sterling, Richard K.
Goodman, Zachary
Aronow, Bruce J.
Perelson, Alan S.
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (246)
[6] Exposure-Response Relationships in Telaprevir Combination Therapy in Treatment-NaiVE Genotype 1 Chronic HCV Patients
Gordon, Stuart C.
Muir, Andrew J.
Garg, Varun
Henshaw, Joshua W.
GASTROENTEROLOGY, 2012, 142 (05) : S931 - S931
[7] Liver fibrosis in treatment-naive HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared
Wandeler, Gilles
Mulenga, Lloyd
Vinikoor, Michael J.
Kovari, Helen
Battegay, Manuel
Calmy, Alexandra
Cavassini, Matthias
Bernasconi, Enos
Schmid, Patrick
Bolton-Moore, Carolyn
Sinkala, Edford
Chi, Benjamin H.
Egger, Matthias
Rauch, Andri
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 51 : 97 - 102
[8] Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis
Montes, Marisa
Nelson, Mark
Girard, Pierre Marie
Sasadeusz, Joe
Horban, Andrzej
Grinsztejn, Beatriz
Zakharova, Natalia
Rivero, Antonio
Lathouwers, Erkki
Janssen, Katrien
Ouwerkerk-Mahadevan, Sivi
Witek, James
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 90 - 91
[9] EXPOSURE-RESPONSE RELATIONSHIPS IN TELAPREVIR COMBINATION THERAPY IN TREATMENT-NAIVE GENOTYPE 1 CHRONIC HCV PATIENTS
Gordon, S. C.
Muir, A. J.
Garg, V.
Henshaw, J.
JOURNAL OF HEPATOLOGY, 2012, 56 : S440 - S440
[10] Effectiveness of Interferon/ribavirin combination therapy in HIV/HCV co-infected patients.
Oliver, DL
Aronson, N
Chatfield, E
Stewart, M
Hilsabeck, RC
Mathews, C
Hassanein, TI
HEPATOLOGY, 2001, 34 (04) : 584A - 584A

← 1 2 3 4 5 →